
### [NCIT:C7134](http://purl.obolibrary.org/obo/NCIT_C7134)
**Label:** Bone Surface (Peripheral) Osteosarcoma

**Subclasses:** [NCIT:C8969](http://purl.obolibrary.org/obo/NCIT_C8969) (Parosteal Osteosarcoma), [NCIT:C6589](http://purl.obolibrary.org/obo/NCIT_C6589) (Childhood Parosteal Osteosarcoma), [NCIT:C123398](http://purl.obolibrary.org/obo/NCIT_C123398) (Childhood Periosteal Osteosarcoma), [NCIT:C53958](http://purl.obolibrary.org/obo/NCIT_C53958) (High Grade Surface Osteosarcoma), [NCIT:C8970](http://purl.obolibrary.org/obo/NCIT_C8970) (Periosteal Osteosarcoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C36140](http://purl.obolibrary.org/obo/NCIT_C36140) (Grade 4 Lesion))) 62.50%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C38323](http://purl.obolibrary.org/obo/NCIT_C38323) (Peripheral Epidermotropic T-Lymphocyte))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C38322](http://purl.obolibrary.org/obo/NCIT_C38322) (Marginal Zone B-Lymphocyte of Nodal Type))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C3832](http://purl.obolibrary.org/obo/NCIT_C3832) (Malaise))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C38317](http://purl.obolibrary.org/obo/NCIT_C38317) (GNAS Gene))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C3826](http://purl.obolibrary.org/obo/NCIT_C3826) (Juvenile Polyp))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C38184](http://purl.obolibrary.org/obo/NCIT_C38184) (ALK Gene))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C38176](http://purl.obolibrary.org/obo/NCIT_C38176) (BCL2 Gene Translocation))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C38175](http://purl.obolibrary.org/obo/NCIT_C38175) (CD44 Messenger RNA Overexpression))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C38174](http://purl.obolibrary.org/obo/NCIT_C38174) (IRF4/MUM1 Messenger RNA Overexpression))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C38173](http://purl.obolibrary.org/obo/NCIT_C38173) (BCL2 Gene mRNA Overexpression))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C38172](http://purl.obolibrary.org/obo/NCIT_C38172) (Cyclin D2 Messenger RNA Overexpression))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C38171](http://purl.obolibrary.org/obo/NCIT_C38171) (PKCbeta1 Messenger RNA Overexpression))) 55.80%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) and (not ([NCIT:C38170](http://purl.obolibrary.org/obo/NCIT_C38170) (LMO2 Messenger RNA Overexpression))) 55.80%


